| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.06 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |